Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Centogene (Group)

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company’s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. Centogene has developed a global proprietary rare disease platform based on our real-world data repository with over 2.0 billion weighted data points from over 450,000 patients representing 115 different countries as of August 31, 2019, or an average of over 500 data points per patient. The Company’s platform includes epidemiologic, phenotypic and genetic data that reflects a global population, and also a biobank of these patients’ blood samples. Centogene believes this represents the only platform that comprehensively analyzes multi-level data to improve the understanding of rare hereditary diseases, which can aid in the identification of patients and improve our pharmaceutical partners’ ability to bring orphan drugs to the market. As of August 31, 2019, the Company collaborated with over 35 pharmaceutical partners for over 30 different rare diseases. *

 

Period Start 2006-01-01 established
Products Industry molecular diagnostics
  Industry 2 diagnostic services
Persons Person Rolfs, Arndt (Univ Rostock Prof + Centogene 201406– CEO + Founder)
  Person 2 Stoffelen, Richard (Centogene 201805 CFO)
     
Region Region Rostock
  Country Germany
  Street 7 Am Strande
  City 18055 Rostock
  Tel +49-381-80113-400
    Address record changed: 2019-11-10
     
Basic data Employees D: 101 to 500 (2017-05-31)
     
    * Document for �About Section�: Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock.
     
   
Record changed: 2020-04-27

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Centogene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top